Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cruveilhier-Baumgarten Syndrome

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Cruveilhier-Baumgarten Syndrome in 3 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS.

Research Excerpts

ExcerptRelevanceReference
" Platelet aggregation induced by ADP and dosing of prostanoid products 6-keto-PGF1alpha, TXB2, PGE2 and LTB4 were also performed."1.34Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension. ( Aguejouf, O; Belon, P; Desplat, V; Doutremepuich, C; Eizayaga, FX, 2007)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skill, NJ1
Theodorakis, NG1
Wang, YN1
Wu, JM1
Redmond, EM1
Sitzmann, JV1
Eizayaga, FX1
Aguejouf, O1
Desplat, V1
Belon, P1
Doutremepuich, C1
Tsugawa, K1
Hashizume, M1
Migou, S1
Kishihara, F1
Kawanaka, H1
Tomikawa, M1
Sugimachi, K1

Other Studies

3 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cruveilhier-Baumgarten Syndrome

ArticleYear
Role of cyclooxygenase isoforms in prostacyclin biosynthesis and murine prehepatic portal hypertension.
    American journal of physiology. Gastrointestinal and liver physiology, 2008, Volume: 295, Issue:5

    Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Epoprostenol; Hypertension,

2008
Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension.
    World journal of gastroenterology, 2007, Oct-14, Volume: 13, Issue:38

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Dinopros

2007
A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury.
    Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:7

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibito

1999